An observational study in Congenital Heart Disease, Cyanotic Congenital Heart Disease and d-Transposition of the Great Arteries, sponsored by Institut National de la Santé Et de la Recherche Médicale, France. Recruiting at 5 sites in France. Open to participants aged Up to 50 Years. Per ClinicalTrials.gov, last updated 2026-07-30.
Sponsored by Institut National de la Santé Et de la Recherche Médicale, France · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Congenital heart disease (CHD) is the leading cause of congenital malformations, representing 1% of live births. Progress in surgical care have led to the dramatic increase in the population of children and adults living with heart disease. As survival is no longer a concern, long-term outcomes have become the major public health issue. Prenatal diagnosis of CHD requiring open-heart surgery can be a traumatic event for expecting mothers and fathers. In the general population, maternal mental health distress is associated with fetal disturbances in the hypothalamic-adrenal-pituitary system axis, restricted intrauterine growth and adverse outcomes in the offspring. It is unknown whether prenatal maternal psychological distress have an impact on neurodevelopmental outcomes in CHD. Our national study seeks to (1) characterize the impact of prenatal maternal psychological distress on neurodevelopmental outcomes at age 1 for children with CHD who undergo neonatal open-heart surgery; (2) investigate the sociodemographic and medical determinants associated with prenatal maternal mental health of women carrying a foetus diagnosed with complex CHD; (3) explore the mediating role of prenatal risk factors (i.e., sociodemographic, medical and maternal coping mechanisms) in the association of prenatal maternal mental health (i.e., distress, anxiety and depression) and neurodevelopment in children with CHD; and (4) explore the impact of paternal or the co-parent's mental health impact on neurodevelopmental outcomes at age 1 in children with CHD. This study is a non-interventional, prospective, and longitudinal study of prenatal maternal mental health and subsequent child's neurodevelopmental and behavioural outcomes. It includes a follow-up period from the 3rd trimester of pregnancy until the child's first year of life. It will include children with a prenatally diagnosed heart defect requiring open-heart surgery within the first weeks of life. Understanding and preventing the neurodevelopmental sequelae of heart disease diagnosed in-utero is a public health priority.
This study is a non-interventional, prospective, and longitudinal study of prenatal maternal mental health and subsequent child's neurodevelopmental and behavioural outcomes in congenital heart disease. It includes a follow-up period from the 3rd trimester of pregnancy until the child's first year of life (between 12 and 18 months). It will include children with a prenatally diagnosed critical heart defect (i.e., cyanotic types of CHD with the potential to cause rapid hypoxemia after birth) requiring neonatal open-heart surgery (within the first weeks of life).
Expecting mothers who agree to participate will undergo comprehensive psychological evaluations conducted by a licensed mental health professional with defined expertise in perinatal mental health. Fathers or co-parent of the child with foetal CHD will also participate in self-reports during the prenatal period. A total of three time points of psychological assessment will be done: Time 1, during the prenatal period, after 28 weeks of gestation); Time 2, an interim self-report assessment using only questionnaires before post-surgery hospital discharge for the baby (after intensive care transfer to hospitalization); and Time 3, 1 year after the birth of their child. Maternal assessments will include standardized self-report measures of stress, anxiety, depression and other psychological symptoms as well as a clinical interview for Time 1 and 2. Co-parent assessment at Time 1 will include self-reports of overall mental health, anxiety and coping skills.
Infant neurodevelopmental and behavioural assessments will be conducted at year 1 (between 12-18 months for the child) during a joint visit of the dyad mother-child. All assessments will be standardized and have French norms and instructions for parents and the child. These assessments will evaluate areas such as cognition, emerging language, and motor skills (gross and fine motor abilities). Socio-behavioural outcomes will also be evaluated at this time. All infant developmental assessments will be administered by paediatric neuropsychologists.
67 studies on the registry are indexed under Hypoplastic Left Heart Syndrome; 12 are open to participants now.
This study's planned enrollment of 174 is above the median of 100 across 23 observational studies indexed under Hypoplastic Left Heart Syndrome.
Browse Hypoplastic Left Heart Syndrome studies →Institut National de la Santé Et de la Recherche Médicale, France is the lead sponsor of 378 studies on the registry; 81 are open to participants now.
Compared within Hypoplastic Left Heart Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Heart Defects, Congenital. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Expecting women diagnosed with a foetal complex congenital heart disease. Fathers or co-parent of prenatally diagnosed children with CHD Children with complex congenital heart disease who require neonatal open-heart surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Inclusion Criteria for the mother of a child diagnosed with CHD:
Inclusion criteria for the father or co-parent:
Inclusion criteria for the child diagnosed with congenital heart disease:
Non-inclusion Criteria for mothers:
Non-inclusion Criteria for fathers or co-parents:
Exclusion Criteria for the mother of a child diagnosed with CHD:
1. The child has not undergone surgery within 60 days of birth.
Exclusion Criteria for children with CHD:
1. Genetic anomalies, brain malformations that may render difficult the neurodevelopmental assessment.
Global Mental Health Self-questionnaire, The Symptom Checklist-90-Revised SCL-90 R (min score 20 - max score 80)
Mental Health Self-Report, Higher scores indicate worse outcomes
Time frame: Time 1 Prenatal Visit and Time 3 1-year old Visit
Bayley Scales of Infant and Toddler Development (BAYLEY-4) (min score 50- max score 150)
Standardized Neurodevelopmental Assessment, Higher scores better outcome, Mean 100; SD 15
Time frame: Time 3 1-year old Visit
State-Trait Anxiety Inventory (STAI-Y) (min score 20 - max score 80)
Anxiety self-report, Higher scores worse outcomes
Time frame: Time 1 Prenatal Visit, Time 2 immediately after the neonatal open-heart surgery during postoperative hospitalization, Postoperative Visit and Time 3 1-year old Visit
Coping Inventory for Stressful Situations (CISS), (min score 20 - max score 80)
Coping self-report, Higher scores better outcomes
Time frame: Time 1 Prenatal Visit and Time 3 1-year old Visit
Post-partum depression Edinburgh Scale (EPDS) (min score 0 - max score 30)
Post-partum depression self-report, Higher scores worse outcomes
Time frame: Time 2 immediately after the neonatal open-heart surgery during postoperative hospitalization, Postoperative Visit
Post-Traumatic Stress Scale (PCL-5), (min score 0 - max score 80)
Self-report scale on PTSD symptoms, Higher scores worse outcomes
Time frame: Time 3 1-year old Visit
Ages and Stages Parent Report, 3rd Edition (min score 0 - max score 60)
Developmental questionnaire for parents, Higher scores worse outcomes
Time frame: Time 3 1-year old Visit
Started Jun 2025 (actual). Primary completion is estimated for Oct 2028, 40 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hypoplastic Left Heart Syndrome →
Institut National de la Santé Et de la Recherche Médicale, France →